These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6433963)

  • 1. Circadian rhythms in theophylline pharmacokinetics and pharmacodynamics in asthmatic children.
    Scott PH; Kramer WG; Smolensky MH; Harrist R
    Br J Clin Pract Suppl; 1984; 35():57-63. PubMed ID: 6433963
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian variation in the absorption of three sustained release theophylline products in asthmatic children and the effect of food on absorption of Somophyllin-CRT.
    Birkett DJ; Coulthard KP; Lines D; Grgurinovich N
    Br J Clin Pract Suppl; 1984; 35():17-23. PubMed ID: 6433954
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
    Nieto A; Mazón A; Caballero L; Gil MC
    An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of two theophylline derivatives in asthmatic patients.
    Jones RW
    J Int Med Res; 1979; 7 Suppl 1():16-21. PubMed ID: 374160
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
    Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
    Mitchell EA; Liang AY
    N Z Med J; 1980 Aug; 92(665):91-3. PubMed ID: 6933343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and fasting intake of sustained release theophylline preparations.
    Pedersen S
    Br J Clin Pract Suppl; 1984; 35():37-9. PubMed ID: 6433957
    [No Abstract]   [Full Text] [Related]  

  • 11. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
    Utama I; Kreukniet J; Meering PG; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronokinetics in steady state of a sustained-release theophylline].
    Segrestaa JM; Dahan R; Houlbert D; Caulin C; Ronnel A; Abella ML
    Therapie; 1984; 39(6):633-7. PubMed ID: 6531736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronokinetic study of various delayed-release theophyllines in children].
    Combes A; Sablayrolles B; Rodriguez F; Labbé A; Patau JP
    Ann Pediatr (Paris); 1988 Mar; 35(3):217-20. PubMed ID: 3377415
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormal absorption of a sustained-release theophylline preparation.
    Newman LJ; Richards W; Church JA; Borzy MS
    Ann Allergy; 1980 Aug; 45(2):95-6. PubMed ID: 7406253
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of theophylline in asthmatic children after multiple oral doses of aminophylline tablets.
    Hasegawa T; Ogura Y; Takeshi K; Mizukami Y
    Arerugi; 1984 Jun; 33(6):303-7. PubMed ID: 6497661
    [No Abstract]   [Full Text] [Related]  

  • 17. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating nocturnal asthma poses challenges.
    Morley TE
    J Am Osteopath Assoc; 1993 Mar; 93(3):318. PubMed ID: 8514530
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacodynamics of theophylline.
    Peck CC; Nichols AI; Baker J; Lenert LL; Ezra D
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):292-7. PubMed ID: 4019957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and pharmacodynamics of proxyphylline in asthmatic children].
    Kalla M; Richter O; Reinhardt D
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):520-6. PubMed ID: 4047067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.